Johnc Jacobs News Today

Serum Institute ships R21/Matrix-M malaria vaccine to Africa, marking a milestone in global fight against malaria.

Serum Institute of India (SII) commenced exporting the R21/Matrix-M malaria vaccine to Africa in collaboration with the University of Oxford and Novavax. The initial shipment, directed to the Central African Republic, is part of efforts to combat malaria in endemic regions, with further doses earmarked for South Sudan and the Democratic Republic of Congo.

Pune-based Serum Institute of India, SII, has dispatched as many as 43,200 doses of malaria vaccine to Africa from its facility on Monday

Achieved revenues in Q4 2023 of $291 million and full year 2023 of $1.0 billion Accelerating progress toward expanding pipeline via Phase 3 COVID-19-Influenza...

Novavax, Inc. (NASDAQ:NVAX) shares fell over 27% on Wednesday as the Covid-19 vaccine maker warned of slowing sales ahead after missing earnings...

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) and Gavi, the Vaccine Alliance (Gavi) today announced they have reached a settlement related to the 2021 Advance...

Novavax and the Vaccine Alliance announced today that they have reached an agreement relating to the Advance Purchase Agreement decided in 2021 concerning Novavaxs COVID-19 prototype vaccine . This...

• Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78% efficacy in the 5–17-month age group over the first year• To date 25 million doses manufactured and ready for roll-out by

Novavax reports that the transformation plan initiated in 2023 will continue this year, focusing primarily on product delivery, financial performance and portfolio expansion. The company also confirms...

Novavax announced today that the UK Medicines and Healthcare products Regulatory Agency has granted marketing authorization for its Nuvaxovid XBB.1.5. to prevent Covid-19 in people aged 12 and over....